title: Heart with circulatory failure secretes and processes atrial natriuretic peptide in a manner different from normal heart.
abstract: The role of catecholamine in atrial natriuretic peptide (ANP) secretion and its secretory mechanism in normal humans is not well defined; therefore, we studied the relationship among ANP, catecholamine, and atrial pressures in 25 patients without cardiovascular disease and in 35 patients with chronic congestive heart failure (CHF, 20 in mitral valve disease and 15 in dilated cardiomyopathy). In patients without cardiovascular disease, right atrial pressure at rest showed a positive correlation (r = 0.80, p less than 0.001) with ANP concentration, whereas left atrial pressure did not. The relation narrowed (r = 0.82) when the bicycle ergometer exercise in the supine position was conducted. Neither adrenalin nor noradrenalin significantly correlated with ANP concentration. In patients with mitral valve disease and dilated cardiomyopathy, the significant relations (r = 0.56 p less than 0.001, r = 0.85 p less than 0.001, respectively) between left atrial pressures and ANP concentrations at rest were observed, and following exercise, induced more significant relations. Right atrial pressures did not correlate positively with ANP concentrations. The increments of ANP concentrations induced by exercise load were markedly reduced compared with those of patients without cardiovascular disease. Although concentrations of both noradrenalin and adrenalin in patients with mitral valve disease and dilated cardiomyopathy at rest were much higher than those without cardiovascular disease, only noradrenalin had a highly positive correlation with ANP concentrations (r = 0.88 p less than 0.001, r = 0.78 p less than 0.001, respectively). Furthermore, the circulating ANP molecular weight forms in all patients studied were analyzed by gel chromatography coupled with radioimmunoassay.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Second Department of Internal Medicine, Kansai Medical University, Osaka, Japan.
authors.forename: H
authors.initials: H
authors.lastname: Matsubara
authors.forename: Y
authors.initials: Y
authors.lastname: Umeda
authors.forename: M
authors.initials: M
authors.lastname: Nishikawa
authors.forename: Y
authors.initials: Y
authors.lastname: Yamane
authors.forename: T
authors.initials: T
authors.lastname: Kurimoto
authors.forename: T
authors.initials: T
authors.lastname: Iwasaka
authors.forename: M
authors.initials: M
authors.lastname: Inada
mesh_terms: D000328:Adult; D000368:Aged; D009320:Atrial Natriuretic Factor / Q000097:blood / Q000378:metabolism*; D002850:Chromatography, Gel; D002908:Chronic Disease; D004837:Epinephrine / Q000502:physiology*; D005080:Exercise Test; D005260:Female; D006325:Heart Atria / Q000503:physiopathology; D006333:Heart Failure / Q000378:metabolism*; D006439:Hemodynamics; D006801:Humans; D008297:Male; D008875:Middle Aged; D008970:Molecular Weight; D009638:Norepinephrine / Q000502:physiology*; D011312:Pressure; D011863:Radioimmunoassay
chemical_list: D009320:Atrial Natriuretic Factor; D009638:Norepinephrine; D004837:Epinephrine